VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT-EHA CAR-T 2019 | Improving treatment outcomes of CAR T-cell therapy

In this video, Stanley Riddell, MD, of Fred Hutchinson Cancer Research Center, Seattle, WA., discusses improving treatment outcomes with CAR T-cell therapy by identifying different targets such as CD22. Dr Riddell goes on to explain the latest research at Fred Hutchinson Cancer Research Center that looks at improving CAR design to improve outcomes. Recorded at the 1st European CAR T-Cell Meeting, held in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and European Hematology Association (EHA).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter